The Center for Infectious Disease Research and Policy (CIDRAP) is helping pave the way for a new era of global involvement to ensure sustainable access to effective antimicrobials.
CIDRAP is one of the 9 founding organizations of CARA – Conscience of Antimicrobial Resistance Accountability- a new alliance which will be introduced at the UN General Assembly High-Level Meeting on Antimicrobial Resistance.
CARA’s goals hit on five key factors: surveillance, preserving effectiveness, universal access, innovation and accountability. The alliance plans to set goals to achieve specific objectives such as universal access to antibiotics, particularly in lower income countries which lack access, and to support innovation to encourage the development of new antimicrobials.
“This newly formed alliance is expected to grow, both in number and in impact. We here at CIDRAP are pleased to be one of the founding organizations of such an essential initiative during a time where the health of the global population is undoubtedly threatened by increasing antimicrobial resistance,” said Michael Osterholm, Regents Professor and Director of CIDRAP.
In July 2016, CIDRAP launched a new initiative called the Antimicrobial Stewardship Project (ASP). It’s aimed at creating an authoritative and credible resource for healthcare providers engaged in antimicrobial stewardship, and addresses the CARA goal of “preserving [antimicrobial] effectiveness.” As part of CARA, CIDRAP will continue to be a critical informational platform for healthcare providers on the frontlines of the antimicrobial resistance crisis.
Other founding organizations include:
- Antibiotic Resistance Action Center (ARAC), the George Washington University
- British Society for Antimicrobial Chemotherapy (BSAC)
- Center for Disease Dynamics, Economics & Policy (CDDEP)
- Center for Global Development (CGD)
- German Center for Infection Research (DZIF)
- The Pew Charitable Trusts
- Norwegian Institute of Public Health (NIPH)
- World Alliance Against Antibiotic Resistance (WAAAR)